‘LIfe-Changing’ Psychedelic, for When Life Is Ending
Posted inCancer Cancer (Journal) Death and Dying Depression (Mental) Drugs (Pharmaceuticals) Food and Drug Administration Hospice Care Journal of Psychopharmacology Ketamine (Drug) Oregon Post-Traumatic Stress Disorder Psilocybin Mushrooms Psychedelic and Hallucinogenic Drugs Psychiatry and Psychiatrists Regulation and Deregulation of Industry Research Veterans Veterans Affairs Department

‘LIfe-Changing’ Psychedelic, for When Life Is Ending

People are turning to psilocybin, ketamine and other treatments for palliative care.
Mushroom-Laced Candy Recall Highlights F.D.A.’s Limited Safety Role
Posted inCenters for Disease Control and Prevention Diamond Shruumz (Prophet Premium Blends LLC) Dietary Supplements and Herbal Remedies Drugs (Pharmaceuticals) Food Food and Drug Administration Food Contamination and Poisoning Poisoning and Poisons Psilocybin Mushrooms Regulation and Deregulation of Industry

Mushroom-Laced Candy Recall Highlights F.D.A.’s Limited Safety Role

More than 150 people were sickened from products sold at smoke and vape shops, providing evidence of the lax regulation of new food items.
F.D.A. Declines to Approve MDMA Therapy, Seeking More Study
Posted inClinical Trials Drug Enforcement Administration Drugs (Pharmaceuticals) Ecstasy (Drug) Food and Drug Administration LSD (Lysergic Acid Diethylamide) Lykos Therapeutics Mental Health and Disorders Post-Traumatic Stress Disorder Psilocybin Mushrooms Psychedelic and Hallucinogenic Drugs Psychology and Psychologists Regulation and Deregulation of Industry Research Therapy and Rehabilitation Veterans

F.D.A. Declines to Approve MDMA Therapy, Seeking More Study

The agency said there was insufficient data to allow the use of a treatment for PTSD that involves the drug known as Ecstasy, according to the company seeking approval.